PennyMac Mortgage Investment Trust (PMT) is back in focus after partnering with PennyMac Financial Services on the new Welcome Home: Athlete Mortgage Program for Team USA athletes, spotlighting its role in specialized residential mortgage financing.

While the Welcome Home program has put PennyMac Mortgage Investment Trust back on investors’ radar, the share price at US$12.12 reflects mixed momentum, with a 30 day share price return of 8.21% set against a 90 day decline of 9.96%, and a longer term 3 year total shareholder return of 40.54%.

If you are curious about where else sentiment and long run returns might be building, this could be a good moment to widen your watchlist with 18 top founder-led companies

With shares at US$12.12, a small discount to the US$13.14 analyst target and an intrinsic value premium, the key question is whether PMT is quietly cheap today or if the market is already pricing in future growth.

Preferred P/E of 12.3x: Is it justified?

On a P/E of 12.3x, PennyMac Mortgage Investment Trust looks more expensive than many Mortgage REIT peers, even though the $12.12 share price sits only modestly below the analyst target.

The P/E ratio compares the share price to earnings per share and is a quick way of seeing how much investors are paying for each dollar of profit. For a mortgage focused REIT like PMT, this often reflects what the market expects from future earnings, interest rate exposure and the stability of its mortgage related cash flows.

Here, the market is paying 12.3x earnings for PMT, while the US Mortgage REITs industry average sits closer to 10x, and the peer group average is around 10.6x. That premium is also slightly above the estimated fair P/E of 11.7x. This is a level the valuation work suggests the market could gravitate toward if expectations cool or earnings do not keep pace.

Result: Price-to-Earnings of 12.3x (OVERVALUED)

However, the recent 25.7% revenue fall and PMT’s focus on credit sensitive and interest rate sensitive assets mean any earnings wobble could quickly challenge that valuation premium.

Another view: DCF points in a different direction

While the 12.3x P/E suggests PMT is priced at a premium to peers, the SWS DCF model paints an even tougher picture. With the share price at $12.12 versus an estimated future cash flow value of $8.80, the stock screens as overvalued using this second lens.

For you as an investor, that gap means less margin for error if cash flows disappoint or stay flat, especially when combined with forecast revenue decline and currently low Return on Equity. The real question is which lens you trust more when those signals do not quite line up.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out PennyMac Mortgage Investment Trust for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 54 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Mixed signals on value and sentiment so far. If you want to move quickly and decide where you stand, start with the balance of 2 key rewards and 4 important warning signs.

Looking for more investment ideas?

If PMT has sharpened your thinking, do not stop here. Use focused stock lists to quickly spot opportunities that better fit your risk and return preferences.

• Target potential mispricings by scanning companies that currently look like 54 high quality undervalued stocks before the crowd fully catches on.
• Prioritise resilience by reviewing 73 resilient stocks with low risk scores so you are not caught holding the most fragile names when conditions change.
• Hunt for freshness by checking the screener containing 25 high quality undiscovered gems that may not yet be on most investors’ radars.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.